PTSD News

The FDA recently granted Breakthrough Therapy Designation to MDMA-assisted psychotherapy for PTSD, according to a release from the Multidisciplinary Association for Psychedelic Studies.

Sexual assault was associated with increased risk for poorer mental health, particularly for PTSD and suicidality.

Limited scientific evidence exists to support the safety and efficacy of cannabis and cannabinoid products for patients with either chronic pain or PTSD, according to data from two reviews published in Annals of Internal Medicine.

Recent findings from two studies suggested the frontopolar cortex plays a significant role in successful prolonged exposure therapy for PTSD.

Army soldiers in a unit with five or more suicide attempts in the past year were twice as likely to attempt suicide, compared with peers in units with no attempts.

According to the U.S. Department of Veterans Affairs, approximately 7 or 8 out of 100 individuals, an estimated 7% or 8% of the population, will have PTSD at some point during their life.

Recent findings indicated associations between deployment stressors and functioning in work and family following military service, with depression playing an important role in female veterans but not males.

Posttraumatic stress disorder is common among patients with familial adenomatous polyposis, for whom medical trauma from surgery could have been a trigger, according to new research presented at the American Society of Colon and Rectal Surgeons Annual Scientific Meeting.

Findings from a systematic review indicated risk assessment methods were sensitive to predictors of suicide and suicide attempts in veterans, but false positives were common, which limited clinical utility.

Tonix Pharmaceuticals recently presented retrospective data that indicated TNX-102 SL significantly improved sustained remission in PTSD.